Norman Fields Gottscho Capital Management’s Novo Nordisk NVO Stock Holding History

Norman Fields Gottscho Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.03M	Sell	42,255 -2	-0%	-$86	0.61%	24
2026 Q1	$1.55M	Buy	42,257 +5,320	+14%	+$252K	0.51%	25
2025 Q4	$1.88M	Sell	36,937 -8,200	-18%	-$419K	0.61%	23
2025 Q3	$2.5M	Buy	45,137 +1,200	+3%	+$70.2K	0.8%	20
2025 Q2	$3.03M	Sell	43,937 -33,275	-43%	-$2.26M	1%	16
2025 Q1	$5.36M	Buy	77,212 +13,480	+21%	+$1.11M	1.8%	13
2024 Q4	$5.48M	Buy	63,732 +19,870	+45%	+$2.15M	1.8%	15
2024 Q3	$5.22M	Sell	43,862 -565	-1%	-$75.4K	1.73%	15
2024 Q2	$6.34M	Sell	44,427 -145	-0.3%	-$19.2K	2.22%	13
2024 Q1	$5.72M	Hold	44,572	–	–	2.13%	13
2023 Q4	$4.61M	Hold	44,572	–	–	1.84%	15
2023 Q3	$4.05M	Hold	44,572	–	–	1.76%	16
2023 Q2	$3.61M	Hold	44,572	–	–	1.52%	18
2023 Q1	$3.55M	Hold	44,572	–	–	1.57%	14
2022 Q4	$3.02M	Hold	44,572	–	–	1.39%	16
2022 Q3	$2.22M	Hold	44,572	–	–	1.07%	19
2022 Q2	$2.48M	Hold	44,572	–	–	1.14%	19
2022 Q1	$2.48M	Hold	44,572	–	–	0.93%	22
2021 Q4	$2.5M	Hold	44,572	–	–	0.93%	22
2021 Q3	$2.14M	Hold	44,572	–	–	0.85%	26
2021 Q2	$1.87M	Hold	44,572	–	–	0.75%	27
2021 Q1	$1.5M	Hold	44,572	–	–	0.65%	32
2020 Q4	$1.56M	Sell	44,572 -1,922	-4%	-$66.4K	0.69%	26
2020 Q3	$1.61M	Sell	46,494 -2,100	-4%	-$70K	0.79%	25
2020 Q2	$1.59M	Sell	48,594 -660	-1%	-$21.1K	0.88%	24
2020 Q1	$1.48M	Hold	49,254	–	–	0.94%	24
2019 Q4	$1.43M	Sell	49,254 -7,786	-14%	-$216K	0.69%	27
2019 Q3	$1.47M	Hold	57,040	–	–	0.74%	30
2019 Q2	$1.46M	Hold	57,040	–	–	0.73%	32
2019 Q1	$1.49M	Sell	57,040 -1,500	-3%	-$36.9K	0.78%	30
2018 Q4	$1.35M	Hold	58,540	–	–	0.79%	31
2018 Q3	$1.38M	Hold	58,540	–	–	0.69%	34
2018 Q2	$1.35M	Sell	58,540 -17,000	-23%	-$404K	0.72%	33
2018 Q1	$1.86M	Hold	75,540	–	–	1.02%	29
2017 Q4	$2.03M	Sell	75,540 -320	-0.4%	-$8.14K	1.11%	30
2017 Q3	$1.83M	Hold	75,860	–	–	1.1%	29
2017 Q2	$1.63M	Hold	75,860	–	–	1.02%	29
2017 Q1	$1.3M	Buy	75,860 +6,400	+9%	+$111K	0.82%	31
2016 Q4	$1.25M	Sell	69,460 -123,100	-64%	-$2.23M	0.84%	30
2016 Q3	$4M	Buy	192,560 +24,500	+15%	+$607K	2.65%	13
2016 Q2	$4.52M	Sell	168,060 -300	-0.2%	-$8.23K	3.16%	10
2016 Q1	$4.56M	Buy	168,360 +3,000	+2%	+$80.4K	3.03%	11
2015 Q4	$4.8M	Hold	165,360	–	–	3.41%	9
2015 Q3	$4.49M	Hold	165,360	–	–	3.07%	11
2015 Q2	$4.53M	Hold	165,360	–	–	2.82%	12
2015 Q1	$4.41M	Hold	165,360	–	–	2.79%	12
2014 Q4	$3.5M	Hold	165,360	–	–	2.29%	18
2014 Q3	$3.94M	Sell	165,360 -3,100	-2%	-$71.3K	2.61%	17
2014 Q2	$3.89M	Buy	168,460 +35,000	+26%	+$773K	2.48%	20
2014 Q1	$3.05M	Sell	133,460 -35,000	-21%	-$746K	2.09%	20
2013 Q4	$3.11M	Buy	168,460 +1,500	+0.9%	+$26.1K	2.1%	20
2013 Q3	$2.83M	Buy	166,960 +2,800	+2%	+$47.1K	2.12%	20
2013 Q2	$2.54M	Buy	+164,160	New	+$2.73M	1.88%	21

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norman Fields Gottscho Capital Management's NVO Position: Q2 2026 in Review

Norman Fields Gottscho Capital Management reduced its Novo Nordisk (NVO) stake by 0% in Q2 2026, selling an estimated $86 and leaving 42,255 shares worth $2.03M. The position accounts for 0.61% of the portfolio, ranked #24.

Norman Fields Gottscho Capital Management first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.34M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Norman Fields Gottscho Capital Management held 42,255 shares of Novo Nordisk worth $2.03M as of Q2 2026.
Norman Fields Gottscho Capital Management sold 2 Novo Nordisk shares in Q2 2026, an estimated $86.
Novo Nordisk made up 0.61% of Norman Fields Gottscho Capital Management's portfolio in Q2 2026, its #24 holding.
Norman Fields Gottscho Capital Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
Norman Fields Gottscho Capital Management's Novo Nordisk position peaked at $6.34M in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Norman Fields Gottscho Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.